Aytu Biopharma (AYTU) EBT (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly EBT of -$5.6 million for Q1 2026, down 246.88% year-over-year from $3.8 million in Q1 2025, and up 47.01% quarter-over-quarter from -$10.6 million in Q4 2025.
Aytu Biopharma (AYTU) EBT (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported EBT for 17 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 246.88% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$33.7 million (down 1165.17% YoY), while the FY2025 annual figure was -$13.7 million, down 32.44% from the prior year.
- EBT rose to -$5.6 million in Q1 2026 per AYTU's latest filing, from -$10.6 million in the prior quarter.
- Across five years, EBT topped out at $3.8 million in Q1 2025 and bottomed at -$53.3 million in Q1 2022.
- Historically, EBT has averaged -$7.3 million across 5 years, with a median of -$2.5 million in 2024.
- On a YoY basis, EBT climbed as much as 316.07% in 2025 and fell as far as 2870.68% in 2025.
- Aytu Biopharma's EBT stood at -$6.7 million in 2022, then soared by 120.9% to $1.4 million in 2023, then plunged by 72.69% to $382000.0 in 2024, then plunged by 2870.68% to -$10.6 million in 2025, then surged by 47.01% to -$5.6 million in 2026.
- Business Quant data shows AYTU's EBT at -$5.6 million in Q1 2026, -$10.6 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Aytu Biopharma | 24.54 Mn | -2.17 Mn | 7.60 Mn | -5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.61 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | -19.44 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | -2.54 Mn |
| Mar 31, 2024 | -1.77 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | -7.47 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.96 Mn |
| Jun 30, 2021 | -18.74 Mn |